MassachusettsEffective Treatment Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Effective Treatment are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Estimate Benchmark Distance to Benchmark
Dialysis patients who were registered on a waiting list for transplantation 29.1 28.2 Achieved: 3% better
Adult end stage renal disease (ESRD) patients who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy 55.4 54.1 Achieved: 2% better
Adult hemodialysis patients with adequate dialysis - (Kt/V) 1.2 or higher 97.1 96.5 Achieved: 1% better
Colorectal cancer deaths per 100,000 population per year 11.6 11.5 0.5%
Patients with colon cancer who received surgical resection of colon cancer that included at least 12 lymph nodes pathologically examined 94.3 95.4 1.1%
Women under age 70 treated for breast cancer with breast-conserving surgery who received radiation therapy to the breast within 1 year of diagnosis 92.5 96.2 3.8%
Breast cancer deaths per 100,000 female population per year 18.5 17.8 4.0%
Ratio of observed deaths to expected deaths among hemodialysis patients 0.9 0.9 4.7%
Adult hemodialysis patients who use arteriovenous fistulas as the primary mode of vascular access 68.6 72.8 5.7%
Persons age 13 and over living with diagnosed HIV who had at least two CD4 or viral load tests performed at least 3 months apart during the last year, among reporting jurisdictions 62.4 66.2 5.8%
Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment 89.3 95.4 6.4%
Persons age 13 and over living with HIV who know their serostatus 85.6 91.9 6.9%
Women with clinical Stage I-IIb breast cancer who received axillary node dissection or sentinel lymph node biopsy (SLNB) at the time of surgery (lumpectomy or mastectomy) 87.9 96.4 8.8%
Measures That Are Close to Benchmark
Measure Estimate Benchmark Distance to Benchmark
Persons age 13 and over living with diagnosed HIV whose most recent viral load in the last 12 months was under 200 copies/mL 68.3 76.1 10.2%
People age 12 and over treated for substance abuse who completed treatment course 54.0 65.2 17.2%
HIV infection deaths per 100,000 population 0.9 0.8 20.0%
Suicide deaths among persons age 12 and over per 100,000 population 11.4 9.4 21.5%
Lung cancer deaths per 100,000 population per year 35.2 27.5 28.2%
Long-stay nursing home residents have depressive symptoms 1.5 1.1 35.4%
Patients with treated chronic kidney failure who received a transplant within 3 years of date of renal failure 17.8 28.8 38.1%
Hemodialysis patients whose hemoglobin level is less than 10 g/dL 23.6 16.1 46.2%
Measures That Are Far From Benchmark
Measure Estimate Benchmark Distance to Benchmark
Drug overdose deaths involving natural and semisynthetic opioids per 100,000 resident population 3.6 1.9 91.1%
People age 12 and over with opioid (either prescription opioid or heroin) use disorder in the past year 0.7 0.3 143.3%
New HIV cases per 100,000 population age 13 and over 10.8 4.2 157.1%
Hospital inpatient stays involving opioid-related diagnoses per 100,000 population 463.8 102.9 350.9%
Drug overdose deaths involving any opioid per 100,000 resident population 29.3 4.0 625.2%
Emergency department visits involving opioid-related diagnoses per 100,000 population 527.1 65.2 707.8%
Drug overdose deaths involving other synthetic opioids (other than methadone) per 100,000 resident population 26.8 0.7 3571.2%
Measures With No Available Benchmark Information
Measure Estimate Benchmark Distance to Benchmark
Adults age 40 and over with diagnosed diabetes who received a flu vaccination in the calendar year